Abstract | BACKGROUND/AIMS: METHODS: RESULTS: The follow-up period was 6.4+/-6.2 years in patients without primary sclerosing cholangitis, 12.7+/-6.2 years in total and 5.1+/-4.0 years (after development of the condition) in patients with primary sclerosing cholangitis (p<0.01). The number of disease attacks (3.7 attacks/yr vs. 0.5 attacks/yr), duration of the active disease (12.9+/-8.0 months vs. 0,3+/-1.0 months), the number of patients in whom corticosteroids were used (47 patients vs. one patient), the number of patients hospitalized (50 patients vs. one patient) and duration of hospitalization (1.2+/-0.8 months vs. 0,1+/-03 months) were higher in patients with than without primary sclerosing cholangitis (after development of the condition) (p<0.001). There was no significant difference in data obtained from patients with and without primary sclerosing cholangitis before development of the disease. CONCLUSIONS:
|
Authors | Erkan Parlak, Aysel Ulker, Canan Alkim, Yasemin Ozderin, Selçuk Dişibeyaz, Bilge Tunç, Ulkü Dağli |
Journal | The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology
(Turk J Gastroenterol)
Vol. 13
Issue 3
Pg. 134-8
(Sep 2002)
ISSN: 1300-4948 [Print] Turkey |
PMID | 16378294
(Publication Type: Journal Article)
|